Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6712 stock hub

TPEX/6712 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/6712is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
12.1B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/6712
In the news

Latest news · TPEX/6712

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.5
P25 12P50 15.5P75 22.5
Trailing P/E28.4
P25 14.4P50 18P75 31.9
ROE25.9
P25 -16.2P50 0.3P75 9.8
ROIC32.6
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/6712 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
224
Groups with data
11
Currency
TWD
Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Taiwan
Country code
TW
Employees Change
45%
Employees Change Percent
91.84
Enterprise value
TWD 11.7B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Biotechnology
Isin
TW0006712003
Last refreshed
2026-05-10
Market cap
TWD 12.1B
Price
TWD 139
Price currency
TWD
Sector
Healthcare
Sic
2836
Symbol
tpex/6712
Website
https://www.ever-supreme.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
3.54%
EV Earnings
27.33x
EV/EBIT
27.31x
EV/EBITDA
25.93x
EV/FCF
21.93x
EV/Sales
11.53x
FCF yield
4.41%
Forward P/E
22.52x
P/B ratio
7.95x
P/E ratio
28.38x
P/S ratio
11.92x
PE Ratio3 Y
36.32x
PE Ratio5 Y
132.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
43.14%
EBITDA Margin
44.3%
FCF margin
52.59%
Gross margin
70.89%
Gross Profit
TWD 721.3M
Gross Profit Growth
9.29%
Gross Profit Growth Q
7.35%
Gross Profit Growth3 Y
20.28%
Net Income
TWD 429.4M
Net Income Growth
16.93%
Net Income Growth Q
-43.34%
Net Income Growth Years
1%
Net Income Growth3 Y
28.86%
Pretax Margin
51.53%
Profit Margin
42.2%
Profitable Years
5
ROA
13.25
Roa5y
10.02
ROCE
27.75
ROE
25.86
Roe5y
22.84
ROIC
32.59
Roic5y
40.09

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr1y
-4.2%
Cagr3y
-3%
Cagr5y
-10.14%
Div CAGR3
28.56%
EPS Growth
17.92
EPS Growth Q
-42.6
EPS Growth Years
1
EPS Growth3 Y
30.45
FCF Growth
22.87%
FCF Growth Q
-24.67%
FCF Growth3 Y
19.19%
OCF Growth
21.8%
OCF Growth Q
-24.67%
OCF Growth3 Y
18.88%
Revenue Growth
8.96x
Revenue Growth Q
3.33x
Revenue Growth Quarters
9x
Revenue Growth Years
6x
Revenue Growth3 Y
17.48x
Revenue Growth5 Y
70.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
TWD 0.49
Assets
TWD 2B
Cash
TWD 435.7M
Current Assets
TWD 752.7M
Current Liabilities
TWD 422.5M
Debt
TWD 38.7M
Debt EBITDA
TWD 0.08
Debt Equity
TWD 0.03
Debt FCF
TWD 0.07
Equity
TWD 1.5B
Interest Coverage
478.7
Liabilities
TWD 477.8M
Long Term Assets
TWD 1.3B
Long Term Liabilities
TWD 55.3M
Net Cash
TWD 396.9M
Net Cash By Market Cap
TWD 3.27
Net Cash Growth
-57.56%
Net Debt EBITDA
TWD -0.88
Net Debt Equity
TWD -0.26
Net Debt FCF
TWD -0.74
Tangible Book Value
TWD 1.5B
Tangible Book Value Per Share
TWD 17.27
WACC
6.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.78
Inventory Turnover
3.8
Net Working Capital
TWD -95.1M
Quick ratio
1.59
Working Capital
TWD 330.1M
Working Capital Turnover
TWD 1.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
0.92%
Dividend Growth
-24.82%
Dividend Growth Years
0%
Dividend per share
TWD 3.5
Dividend Years
5
Dividend Yield
2.53%
Ex Div Date
2026-04-16
Last Dividend
TWD 3.5
Payout Frequency
Annual
Payout Ratio
94.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-4.2%
200-day SMA
156.2
3Y total return
-8.75%
50-day SMA
140.6
50-day SMA vs 200-day SMA
50under200
5Y total return
-41.4%
All Time High
348.4
All Time High Change
-60.25%
All Time High Date
2021-04-06
All Time Low
40.65
All Time Low Change
240.7%
All Time Low Date
2018-10-26
ATR
3.41
Beta
0.41
Beta1y
0.46
Beta2y
0.42
Ch YTD
-15.55
High
140
High52
188
High52 Date
2025-10-01
High52ch
-26.33%
Low
137
Low52
127
Low52 Date
2026-04-30
Low52ch
9.06%
Ma50ch
-1.51%
Price vs 200-day SMA
-11.36%
RSI
52.04
RSI Monthly
41.78
RSI Weekly
36.15
Sharpe ratio
-0.32x
Sortino ratio
-0.16
Total Return
3.44%
Tr YTD
-13.44
Tr1m
0.33%
Tr1w
4.53%
Tr3m
-6.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
TWD 439M
Operating Income Growth
4.23
Operating Income Growth Q
-7.2
Operating Income Growth3 Y
15.65
Operating margin
43.14

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
62,769,895%
Net Borrowing
-10,713,000
Shares Insiders
3.78%
Shares Institutions
1.08%
Shares Out
87,597,000
Shares Qo Q
0.01%
Shares Yo Y
-0.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
TWD 472.7M
Average Volume
303,030x
Bv Per Share
17.43
CAPEX
TWD -1.3M
Ch1m
-2.12
Ch1w
4.53
Ch1y
-6.53
Ch3m
-8.88
Ch3y
-16.99
Ch5y
-48.02
Ch6m
-13.17
Change
0%
Change From Open
-0.36
Close
138.5
Days Gap
0.36
Depreciation Amortization
11,787,000
Dollar Volume
25,260,322.5
Earnings Date
2026-04-14
EBIT
TWD 439M
EBITDA
TWD 450.8M
EPS
TWD 4.88
F Score
6
FCF
TWD 535.1M
FCF EV Yield
4.56x
FCF Per Share
TWD 6.11
Financing CF
-750,128,000
Fiscal Year End
December
Founded
2,016
Graham Number
43.74339
Graham Upside
-68.42
Income Tax
TWD 94.9M
Investing CF
134,268,000
Is Primary Listing
1
Last Earnings Date
2025-11-12
Last Report Date
2025-12-31
Last Split Date
2025-06-03
Last Split Type
Forward
Lynch Fair Value
TWD 122
Lynch Upside
-11.91
Ma150
156.5
Ma150ch
-11.49%
Ma20
136.6
Ma20ch
1.37%
Net CF
-79,514,000
Open
139
P FCF Ratio
22.67
P OCF Ratio
22.62
Payment Date
2026-05-08
Position In Range
50
Ppne
74,676,000
Price Date
2026-05-08
Price EBITDA
TWD 26.91
Ptbv Ratio
8.02
Relative Volume
0.6x
Revenue
1,017,505,000x
SBC By Revenue
6.13x
Share Based Comp
62,396,000
Tax By Revenue
9.33x
Tax Rate
18.1%
Tr6m
-11%
Volume
182,385
Z Score
19.21
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TPEX/6712 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.5%
$3.50 annual per share
Payout ratio
+95.0%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
+3.4%
Next ex-dividend date: 2026-04-16
Performance

TPEX/6712 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-4.2%
S&P 500 1Y: n/a
3Y total return
-8.7%
S&P 500 3Y: n/a
5Y total return
-41.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TPEX/6712?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.1%
Share of float held by funds and institutions
Insider ownership
+3.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.9%
Negative means the company is buying back shares.
Technical

TPEX/6712 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.0
Neutral momentum band
Price vs 200-day MA
-11.4%
50/200-day relationship not available
Beta (5Y)
0.41
Less volatile than the market
Sharpe ratio
-0.32
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/6712

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6712 stock rating?

tpex/6712 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6712 analysis?

The full report lives at /stocks/tpex/6712/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6712?

The latest report frames tpex/6712 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6712 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.